Patient-Reported Outcome Measures for Mohs Reconstruction: A Systematic Review

被引:0
作者
Garg, Neha [1 ]
Mandloi, Shreya [1 ]
Queenan, Natalia [2 ]
Trivedi, Jay [2 ]
Mccann, Adam [1 ]
Xu, Vivian [1 ]
Amin, Dev [1 ]
Krein, Howard [1 ]
Heffelfinger, Ryan [1 ]
机构
[1] Thomas Jefferson Univ Hosp, Dept Otolaryngol Head & Neck Surg, 925 Chestnut St,Floor 6, Philadelphia, PA 19107 USA
[2] Thomas Jefferson Univ, Sidney Kimmel Med Coll, Dept Otolaryngol Head & Neck Surg, Philadelphia, PA USA
关键词
facial reconstruction; Mohs micrographic surgery; patient-reported outcome measures; quality of life; systematic review; QUALITY-OF-LIFE; NONMELANOMA SKIN-CANCER; ARABIC VERSION; SKINDEX-16; INDEX; QUESTIONNAIRE; VALIDATION; INSTRUMENT; DISEASE; COSMIN;
D O I
10.1002/oto2.70054
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
ObjectiveMohs micrographic surgery (MMS) and subsequent reconstructive procedures for the treatment of facial nonmelanoma skin cancers (NMSCs) significantly impact quality of life (QoL). A validated patient-reported outcome measure (PROM) for patients who undergo Mohs reconstruction is not yet established. This study aims to systematically assess the quality of existing PROMs to determine their effectiveness in capturing the challenges faced after Mohs reconstruction for facial NMSC.Data SourcesA systematic review following established Preferred Reporting Items for Systematic Reviews and Meta-analyses guidelines was performed. Medline, PubMed, Scopus, and Cochrane databases were searched using keywords relevant to MMS, NMSC, facial reconstruction, QoL, and PROMs.Review MethodsInclusion and exclusion criteria were used to compile eligible PROMs. Methodological quality and psychometric properties of PROMs were evaluated using COnsensus-based Standards for the Selection of Health Measurement Instruments (COSMIN) criteria.ResultsOf 2997 articles, 78 met the inclusion criteria. Of these, 45 studies utilized a PROM as an outcome measure, and 33 reported PROM development or validation. COSMIN assessment demonstrated that the FACE-Q Skin Cancer Module and Facial Skin Cancer Index have the strongest validation. The Mohs Reconstruction Questionnaire-12 (MRQ-12) was the only PROM specific to this population of interest; however, it has not undergone psychometric property assessment.ConclusionVarious PROMs have been utilized to assess QoL for patients undergoing facial reconstructive surgery after MMS. A clinically validated PROM specific to this patient population is required to gain deeper insight into these emotional impacts. Further validation and psychometric testing of the MRQ-12 may be beneficial.
引用
收藏
页数:10
相关论文
共 61 条
[31]  
Rhee J.S., Matthews B.A., Neuburg M., Logan B.R., Burzynski M., Nattinger A.B., The Skin Cancer Index: clinical responsiveness and predictors of quality of life, Laryngoscope, 117, 3, pp. 399-405, (2007)
[32]  
Matthews B.A., Rhee J.S., Neuburg M., Burzynski M.L., Nattinger A.B., Development of the facial skin care index: a health-related outcomes index for skin cancer patients, Dermatol Surg, 32, 7, pp. 924-934, (2006)
[33]  
Samela T., Raimondi G., Sampogna F., Et al., Testing some psychometric properties of the Italian version of the Skin Cancer Index: a questionnaire for measuring quality of life in patients with non-melanoma skin cancer, Front Psychol, 13, (2022)
[34]  
de Troya-Martin M., Rivas-Ruiz F., Blazquez-Sanchez N., Et al., A Spanish version of the Skin Cancer Index: a questionnaire for measuring quality of life in patients with cervicofacial nonmelanoma skin cancer, Br J Dermatol, 172, 1, pp. 160-168, (2015)
[35]  
Beal B.T., White E.K., Behera A.K., Et al., A novel, disease-specific self-report instrument to measure body image concerns in patients with head and neck skin cancer, Dermatol Surg, 44, 1, pp. 17-24, (2018)
[36]  
Burdon-Jones D., Thomas P., Baker R., Quality of life issues in nonmetastatic skin cancer, Br J Dermatol, 162, 1, pp. 147-151, (2010)
[37]  
Burdon-Jones D., Gibbons K., The Skin Cancer Quality of Life Impact Tool (SCQOLIT): a validated health-related quality of life questionnaire for non-metastatic skin cancers, J Eur Acad Dermatol Venereol, 27, 9, pp. 1109-1113, (2013)
[38]  
Karakok H., Bostanci S., Akay B.N., Caliskan D., Ates C., Kose S.K., Validation of the Turkish Version of the Skin Cancer Quality of Life Impact Tool (SCQOLIT): a health-related quality of life questionnaire for non-metastatic melanoma and non-melanoma skin cancer, Dermatol Pract Concept, 13, 1, (2023)
[39]  
Chren M.M., Lasek R.J., Quinn L.M., Mostow E.N., Zyzanski S.J., Skindex, a quality-of-life measure for patients with skin disease: reliability, validity, and responsiveness, J Invest Dermatol, 107, 5, pp. 707-713, (1996)
[40]  
Chren M.M., Lasek R.J., Sahay A.P., Sands L.P., Measurement properties of Skindex-16: a brief quality-of-life measure for patients with skin diseases, J Cutan Med Surg, 5, 2, pp. 105-110, (2001)